? Pilot Projects Core The objectives of the pilot project core are to provide the funding for projects that will test new, significant, innovative and provocative hypotheses. These projects will provide the opportunity for scholars to use these preliminary data in an expanded investigation funded by external grant submissions. In addition, the pilot program allows for the upward career trajectory for new young scientists with cutting edge ideas to move forward within the academic research community supporting drug abuse research. Funding will be provided to several categories of investigators: young investigators, investigators who have been funded by external sources for their work in the drug abuse field but have new collaborations and hypotheses that require preliminary testing before seeking external funding, or investigators who have been successfully working in another area of biomedical research and have a novel project that requires preliminary data to transition to the area of drug abuse research. Collaborative projects among scholars from more than one of these groups will be given priority for funding. Scholars from throughout the university will be encouraged to participate in this program and the Dean of the School of Medicine, the Dean of the School of Pharmacy, and the Vice President for Research and Innovation have committed to provide matching funds for all pilot projects funded. The scholars funded by this mechanism will have an advantage in seeking support from the VCU School of Medicine Research Funding Program, the campus-wide A.D. Williams Research Program and the VCU President's Research Initiative Program. All levels of the university administration will continue to be committed to support drug abuse researchers through this Center of Excellence. Historically, it is impressive that scholars supported by the pilot project programs in the past have had at least a three-fold higher success rate for funding their external (NIH, etc.) applications than the national average. Thus, the pilot programs not only lead to increased prevalence of funding for such novel projects, but significantly more collaborative scientific projects.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Center Core Grants (P30)
Project #
5P30DA033934-07
Application #
9944642
Study Section
Special Emphasis Panel (ZDA1)
Project Start
Project End
Budget Start
2020-04-01
Budget End
2021-03-31
Support Year
7
Fiscal Year
2020
Total Cost
Indirect Cost
Name
Virginia Commonwealth University
Department
Type
DUNS #
105300446
City
Richmond
State
VA
Country
United States
Zip Code
23298
Donvito, Giulia; Nass, Sara R; Wilkerson, Jenny L et al. (2018) The Endogenous Cannabinoid System: A Budding Source of Targets for Treating Inflammatory and Neuropathic Pain. Neuropsychopharmacology 43:52-79
Wolstenholme, Jennifer T; Bowers, M Scott; Pais, Alexander B et al. (2018) Dietary Omega-3 Fatty Acids Differentially Impact Acute Ethanol-Responsive Behaviors and Ethanol Consumption in DBA/2J Versus C57BL/6J Mice. Alcohol Clin Exp Res :
Hermes, Douglas J; Xu, Changqing; Poklis, Justin L et al. (2018) Neuroprotective effects of fatty acid amide hydrolase catabolic enzyme inhibition in a HIV-1 Tat model of neuroAIDS. Neuropharmacology 141:55-65
Mischel, Ryan A; Dewey, William L; Akbarali, Hamid I (2018) Tolerance to Morphine-Induced Inhibition of TTX-R Sodium Channels in Dorsal Root Ganglia Neurons Is Modulated by Gut-Derived Mediators. iScience 2:193-209
Shin, Myungsun; Snyder, Helena W; Donvito, Giulia et al. (2018) Liposomal Delivery of Diacylglycerol Lipase-Beta Inhibitors to Macrophages Dramatically Enhances Selectivity and Efficacy in Vivo. Mol Pharm 15:721-728
Gonek, Maciej; McLane, Virginia D; Stevens, David L et al. (2018) CCR5 mediates HIV-1 Tat-induced neuroinflammation and influences morphine tolerance, dependence, and reward. Brain Behav Immun 69:124-138
Curry, Zachary A; Wilkerson, Jenny L; Bagdas, Deniz et al. (2018) Monoacylglycerol Lipase Inhibitors Reverse Paclitaxel-Induced Nociceptive Behavior and Proinflammatory Markers in a Mouse Model of Chemotherapy-Induced Neuropathy. J Pharmacol Exp Ther 366:169-183
Cooper, Ziva D; Poklis, Justin L; Liu, Fei (2018) Methodology for controlled administration of smoked synthetic cannabinoids JWH-018 and JWH-073. Neuropharmacology 134:92-100
Withey, Sarah L; Hill, Rob; Lyndon, Abigail et al. (2017) Effect of Tamoxifen and Brain-Penetrant Protein Kinase C and c-Jun N-Terminal Kinase Inhibitors on Tolerance to Opioid-Induced Respiratory Depression in Mice. J Pharmacol Exp Ther 361:51-59
Wolf, Carl E; Poklis, Justin L; Cumpston, Kirk et al. (2017) Acute dilated cardiomyopathy and myocardial injury after combined 4-fluoroamphetamine and modafinil ingestion. Drug Test Anal 9:657-659

Showing the most recent 10 out of 93 publications